Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study
Abstract
BACKGROUND: Patients with amnestic mild cognitive impairment (MCI) have greater risk of conversion to Alzheimer disease (AD). Increased brain amyloid burden in AD and MCI has been demonstrated with PET using [(11)C] Pittsburgh compound B (PiB) as a tracer. OBJECTIVE: To evaluate change in β-amyloid deposition in with MCI during 2-year follow-up. METHODS: Patients with MCI and controls were studied with [(11)C] PiB PET, MRI, and neuropsychometry at baseline and these investigations were repeated in patients with MCI after follow-up. RESULTS: Those patients with MCI converting to AD during follow-up had greater [(11)C] PiB retention in the posterior cingulate (p=0.020), in the lateral frontal cortex (p=0.006), in the temporal cortex (p=0.022), in the putamen (p=0.041), and in the caudate nucleus (p=0.025) as compared to nonconverters. In converters, there was no significant change in [(11)C] PiB uptake, whereas an increase was seen as compared to baseline in nonconverters in the anterior and posterior cingulate, temporal and parietal cortices, and putamen. Hippocampal atrophy was greater in converters at baseline than in nonconverters, but increased significantly in both groups during follow-up. CONCLUSIONS: Hippocampal atrophy and amyloid deposition seem to dissociate during the evolution of MCI, the atrophy increasing clearly and [(11)C] PiB retention changing modestly when conversion to AD occurs. Longer follow-up is needed to determine whether nonconverters would convert to AD later, which would suggest accelerated [(11)C] PiB retention preceding clinical conversion.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Microglia fundamentally participate in the development and progression of Alzheimer's disease.
“indicating a fundamental participation of microglia in the development and progression of AD.”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [151]
In subjects with high amounts of amyloid-β but no dementia, PET imaging shows decreased microglia activation.
“PET imaging studies have shown that subjects with high amounts of amyloid-β, but no dementia, had decreased microglia activation [151–153]”
From Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation (2019) · cites this paper as [151]
Cites
Mild cognitive impairment as a diagnostic entity
Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works
Scheltens, P., Leys, D., Barkhof, F., Huglo, D. G., Weinstein, H. C., Vermersch, P., Kuiper, M. A., Steinling, M., Wolters, E. C., & Valk, J. (1992) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.10.967 · Cited by 1,781 · see citing works
Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment
Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · see citing works
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099 · see citing works
[ <sup>11</sup> C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036 · see citing works
Jack, C. R., Lowe, V. J., Senjem, M. L., Weigand, S. D., Kemp, B. J., Shiung, M. M., Knopman, D. S., Boeve, B. F., Klunk, W. E., Mathis, C. A., et al. (2008) · Brain · doi:10.1093/brain/awm336 · Cited by 958 · see citing works
Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789 · see citing works
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785 · see citing works
PET imaging of amyloid deposition in patients with mild cognitive impairment
Forsberg, A., Engler, H., Almkvist, O., Blomquist, G., Hagman, G., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.029 · Cited by 725 · see citing works
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 614 · see citing works
Siebner, H. R., Riemenschneider, M. J., Willoch, F., Minoshima, S., Schwaiger, M., Kurz, A., Drzezga, A. E., & Lautenschlager, N. T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1194-1 · Cited by 603 · see citing works
Conversion of amyloid positive and negative MCI to AD over 3 years
Okello, A., Koivunen, J., Edison, P., Archer, H. A., Turkheimer, F., Någren, K., Bullock, R. M., Walker, Z., Kennedy, A. M., Fox, N. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b23564 · Cited by 522 · see citing works
Self-citationPET amyloid ligand [ 11 C]PIB uptake is increased in mild cognitive impairment
Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., Viitanen, M. H., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000260969.94695.56 · Cited by 306 · see citing works
Self-citationVoxel-based analysis of PET amyloid ligand [ 11 C]PIB uptake in Alzheimer disease
Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., Viitanen, M. H., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000240117.55680.0a · Cited by 227 · see citing works
Self-citationFollow-up of [ 11 C]PIB uptake and brain volume in patients with Alzheimer disease and controls
Scheinin, N. M., Aalto, S., Koikkalainen, J. R., Lötjönen, J. M. P., Karrasch, M., Kemppainen, N. M., Viitanen, M. H., Någren, K., Helin, S., Scheinin, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bacf1b · Cited by 128 · see citing works
Self-citationImpact of amyloid imaging on drug development in Alzheimer's disease
Mathis, C. A., Lopresti, B. J., & Klunk, W. E. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.06.015 · Cited by 118 · see citing works
PET Amyloid Ligand [11C]PIB Uptake and Cerebrospinal Fluid β-Amyloid in Mild Cognitive Impairment
Koivunen, J., Pirttilä, T., Kemppainen, N. M., Aalto, S., Herukka, S., Jauhianen, A. M., Hänninen, T., Hallikainen, M., Någren, K., Rinne, J. O., et al. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000163927 · Cited by 101 · see citing works
Self-citationThe search for antecedent biomarkers of Alzheimer's disease
Fagan, A. M., Csernansky, C. A., Morris, J. C., & Holtzman, D. M. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8404 · Cited by 29 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Dubois, B., Feldman, H. H., Jacova, C., Hampel, H., Molinuevo, J. L., Blennow, K., DeKosky, S. T., Gauthier, S., Selkoe, D., Bateman, R., et al. (2014) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70090-0 · Cited by 3,321 · see citing works
Brain-Derived Neurotrophic Factor in Brain Disorders: Focus on Neuroinflammation
Lima Giacobbo, B., Doorduin, J., Klein, H. C., Dierckx, R. A. J. O., Bromberg, E., & de Vries, E. F. J. (2019) · Molecular Neurobiology · doi:10.1007/s12035-018-1283-6 · Cited by 750 · see citing works
Rathore, S., Habes, M., Iftikhar, M. A., Shacklett, A., & Davatzikos, C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.03.057 · Cited by 622 · see citing works
AD dementia risk in late MCI, in early MCI, and in subjective memory impairment.
Jessen, F., Wolfsgruber, S., Wiese, B., Bickel, H., Mösch, E., Kaduszkiewicz, H., Pentzek, M., Riedel‐Heller, S. G., Luck, T., Fuchs, A., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.09.017 · Cited by 511 · see citing works
Disrupted Functional Brain Connectome in Individuals at Risk for Alzheimer's Disease
Wang, J., Zuo, X., Dai, Z., Xia, M., Zhao, Z., Zhao, X., Jia, J., Han, Y., & He, Y. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.026 · Cited by 432 · see citing works
Chételat, G., Joie, R. L., Villain, N., Perrotin, A., Sayette, V. D. L., Eustache, F., & Vandenberghe, R. R. (2013) · NeuroImage Clinical · doi:10.1016/j.nicl.2013.02.006 · Cited by 353 · see citing works
Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia
Ewers, M., Sperling, R. A., Klunk, W. E., Weiner, M. W., & Hampel, H. J. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.005 · Cited by 345 · see citing works
van Oostveen, W. M., & de Lange, E. C. M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042110 · Cited by 297 · see citing works
Villain, N., Chételat, G., Grassiot, B., Bourgeat, P., Jones, G., Ellis, K. A., Ames, D., Martins, R. N., Eustache, F., Salvado, O., et al. (2012) · Brain · doi:10.1093/brain/aws125 · Cited by 255 · see citing works
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline
Doraiswamy, P. M., Sperling, R. A., Coleman, R. E., Johnson, K. A., Reiman, E. M., Davis, M. D., Grundman, M., Sabbagh, M. N., Sadowsky, C., Fleisher, A., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182661f74 · Cited by 228 · see citing works
Biomarkers for the Early Detection and Progression of Alzheimer's Disease
Counts, S. E., Ikonomovic, M. D., Mercado, N., Vega, I. E., & Mufson, E. J. (2017) · Neurotherapeutics · doi:10.1007/s13311-016-0481-z · Cited by 224 · see citing works
Rowe, C. C., Bourgeat, P., Ellis, K. A., Brown, B., Lim, Y. Y., Mulligan, R., Jones, G., Maruff, P., Woodward, M., Price, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.24040 · Cited by 222 · see citing works
Khazaee, A., Ebrahimzadeh, A., & Abbas Babajani-feremi, A. (2015) · Brain Imaging and Behavior · doi:10.1007/s11682-015-9448-7 · Cited by 213 · see citing works
Alzheimer disease: new concepts on its neurobiology and the clinical role imaging will play
Jack, C. R. (2012) · Radiology · doi:10.1148/radiol.12110433 · Cited by 211 · see citing works
Smailagic, N., Vacante, M., Hyde, C., Martin, S., Ukoumunne, O. C., & Sachpekidis, C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010632.pub2 · Cited by 229 · see citing works
Early detection of Alzheimer's disease using PiB and FDG PET
Cohen, A. D., & Klunk, W. E. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.05.001 · Cited by 202 · see citing works
Florbetapir F 18 amyloid PET and 36-month cognitive decline:a prospective multicenter study
AV45-A11 Study Group, Doraiswamy, P. M., Sperling, R. A., Johnson, K., Reiman, E. M., Wong, T. Z., Sabbagh, M. N., Sadowsky, C. H., Fleisher, A. S., Carpenter, A., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2014.9 · Cited by 195 · see citing works
Impact of molecular imaging on the diagnostic process in a memory clinic
Ossenkoppele, R., Prins, N. D., Pijnenburg, Y. A. L., Lemstra, A. W., van der Flier, W. M., Adriaanse, S. F., Windhorst, A. D., Handels, R. L. H., Wolfs, C. A. G., Aalten, P., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.07.003 · Cited by 194 · see citing works
Plasma microRNA biomarkers for detection of mild cognitive impairment
Sheinerman, K. S., Tsivinsky, V. G., Crawford, F., Mullan, M. J., Abdullah, L., & Umansky, S. R. (2012) · Aging · doi:10.18632/aging.100486 · Cited by 158 · see citing works
Morris, J. C. (2012) · Archives of Neurology · doi:10.1001/archneurol.2011.3152 · Cited by 176 · see citing works
Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents
Mathis, C. A., Mason, N. S., Lopresti, B. J., & Klunk, W. E. (2012) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2012.07.001 · Cited by 176 · see citing works
Synaptic Change in the Posterior Cingulate Gyrus in the Progression of Alzheimer's Disease
Scheff, S. W., PRICE, D. A., Ansari, M. A., Roberts, K. N., Schmitt, F. A., Ikonomović, M. D., & Mufson, E. J. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-141518 · Cited by 163 · see citing works
Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET
Ossenkoppele, R., Tolboom, N., Foster‐Dingley, J. C., Adriaanse, S. F., Boellaard, R., Yaqub, M. M., Windhorst, A. D., Barkhof, F., Lammertsma, A. A., Scheltens, P., et al. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2102-3 · Cited by 161 · see citing works
The diagnostic value of FDG and amyloid PET in Alzheimer’s disease—A systematic review
Rice, L., & Bisdas, S. (2017) · European Journal of Radiology · doi:10.1016/j.ejrad.2017.07.014 · Cited by 150 · see citing works
The Development, Past Achievements, and Future Directions of Brain PET
Jones, T., & Rabiner, E. (2012) · Journal of Cerebral Blood Flow and Metabolism · doi:10.1038/jcbfm.2012.20 · Cited by 128 · see citing works
Hampel, H. J., Lista, S., & Khachaturian, Z. S. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.05.2116 · Cited by 138 · see citing works
Cerebral amyloid PET imaging in Alzheimer’s disease
Jack, C. R., Barrio, J. R., & Kepe, V. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1185-7 · Cited by 131 · see citing works
Zhang, S., Han, D., Tan, X., Feng, J., Guo, Y., & Ding, Y. (2012) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02845.x · Cited by 121 · see citing works
Identifying incipient dementia individuals using machine learning and amyloid imaging
Mathotaarachchi, S., Pascoal, T. A., Shin, M., Benedet, A. L., Kang, M. S., Beaudry, T., Fonov, V. S., Gauthier, S., & Rosa-Neto, P. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.06.027 · Cited by 118 · see citing works
In vivo characterization of the early states of the amyloid-beta network
Sepulcre, J., Sabuncu, M. R., Becker, A., Sperling, R., & Johnson, K. A. (2013) · Brain · doi:10.1093/brain/awt146 · Cited by 117 · see citing works
Diniz, B. S., Sibille, E., Ding, Y., Tseng, G., Aizenstein, H. J., Lotrich, F., Becker, J. T., Lopez, O. L., Lotze, M. T., Klunk, W. E., et al. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.76 · Cited by 116 · see citing works
Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease
Teipel, S. J., Heinsen, H., Amaro, E., Grinberg, L. T., Krause, B. J., & Grothe, M. J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.09.029 · Cited by 111 · see citing works
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease
Cohen, A. D., Landau, S. M., Snitz, B. E., Klunk, W. E., Blennow, K., & Zetterberg, H. (2018) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2018.12.004 · Cited by 107 · see citing works
O’Dell, R. S., Mecca, A. P., Chen, M.-K., Naganawa, M., Toyonaga, T., Lu, Y., Godek, T. A., Harris, J. E., Bartlett, H. H., Banks, E. R., et al. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-020-00742-y · Cited by 104 · see citing works
Ferreira, L. K., & Busatto, G. F. (2011) · Clinics · doi:10.1590/s1807-59322011001300003 · Cited by 102 · see citing works
Synergistic interaction between amyloid and tau predicts the progression to dementia
Pascoal, T. A., Mathotaarachchi, S., Shin, M., Benedet, A. L., Mohades, S., Wang, S., Beaudry, T., Kang, M. S., Soucy, J., Labbe, A., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.11.005 · Cited by 101 · see citing works
Using Pittsburgh Compound B for In Vivo PET Imaging of Fibrillar Amyloid-Beta
Cohen, A. D., Rabinovici, G. D., Mathis, C. A., Jagust, W. J., Klunk, W. E., & Ikonomović, M. D. (2012) · Advances in pharmacology · doi:10.1016/b978-0-12-394816-8.00002-7 · Cited by 99 · see citing works
Dementia in Patients Hospitalized with Stroke: Rates, Time Course, and Clinico-Pathologic Factors
Pendlebury, S. T. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2012.00837.x · Cited by 98 · see citing works
Biomarkers in Neurodegenerative Diseases
Jeromin, A., & Bowser, R. (2017) · Advances in Neurobiology · doi:10.1007/978-3-319-57193-5_20 · Cited by 92 · see citing works
Wolk, D., Sadowsky, C., Safirstein, B., Rinne, J., Duara, R., Perry, R., Agronin, M., Gámez, J. E., Shi, J., Ivanoiu, A., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.0894 · Cited by 83 · see citing works
Self-citationRinne, J. O., Wong, D. F., Wolk, D. A., Leinonen, V., Arnold, S. E., Buckley, C. J., Smith, A. P. L., McLain, R. W., Sherwin, P. F., Farrar, G., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1051-z · Cited by 82 · see citing works
Self-citationRallabandi, V. P. S., & Seetharaman, K. (2022) · Biomedical Signal Processing and Control · doi:10.1016/j.bspc.2022.104312 · Cited by 82 · see citing works
Biomarkers in Alzheimer's disease with a special emphasis on event-related oscillatory responses
Yener, G., & Başar, E. (2013) · Supplements to Clinical neurophysiology · doi:10.1016/b978-0-7020-5307-8.00020-x · Cited by 82 · see citing works
Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases
Drzezga, A. E., Barthel, H., Minoshima, S., & Sabri, O. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.129254 · Cited by 81 · see citing works
Aβ and cognitive change: Examining the preclinical and prodromal stages of Alzheimer's disease
Lim, Y. Y., Maruff, P. T., Pietrzak, R. H., Ellis, K. A., Darby, D., Ames, D. J., Harrington, K., Martins, R. N., Masters, C. L., Szoeke, C. E. I., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.11.005 · Cited by 80 · see citing works
Chiotis, K., Saint‐Aubert, L., Boccardi, M., Gietl, A. F., Picco, A., Varrone, A., Garibotto, V., Herholz, K., Nobili, F. M., Nordberg, A. K., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.07.012 · Cited by 75 · see citing works
Schreiber, S., Landau, S., Fero, A., Schreiber, F., & Jagust, W. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.1633 · Cited by 83 · see citing works
Ma, Y., Zhang, S., Li, J., Zheng, D., Guo, Y., Feng, J., & Ren, W.-D. (2014) · Medicine · doi:10.1097/md.0000000000000150 · Cited by 71 · see citing works
Koychev, I. G., on behalf of the Deep and Frequent Phenotyping study team (http://www.dementiastudy.co.uk/), Gunn, R. N., Firouzian, A., Lawson, J., Zamboni, G., Ridha, B. H., Sahakian, B. J., Rowe, J. B., Thomas, A. J., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170129 · Cited by 67 · see citing works
Zhang, S., Smailagic, N., Hyde, C., Noel-Storr, A. H., Takwoingi, Y., McShane, R., & Feng, J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010386.pub2 · Cited by 66 · see citing works
Clinical and research diagnostic criteria for Alzheimer's disease
Sarazin, M., de Souza, L. C., Lehéricy, S., & Dubois, B. (2012) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2011.11.004 · Cited by 64 · see citing works
Cilento, E. M., Jin, L., Stewart, T., Shi, M., Sheng, L., & Zhang, J. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14635 · Cited by 60 · see citing works
Heurling, K., Leuzy, A., Zimmer, E. R., Lubberink, M., & Nordberg, A. K. (2015) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-015-3208-1 · Cited by 59 · see citing works
Han, S. D., Arfanakis, K., Fleischman, D. A., Leurgans, S. E., Tuminello, E. R., Edmonds, E. C., & Bennett, D. A. (2011) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617711001299 · Cited by 59 · see citing works
A Survey of FDG- and Amyloid-PET Imaging in Dementia and GRADE Analysis
Perani, D., Schillaci, O., Padovani, A., Nobili, F. M., Iaccarino, L., Pasquale, D. R., Frisoni, G. B., & Caltagirone, C. (2014) · BioMed Research International · doi:10.1155/2014/785039 · Cited by 59 · see citing works
Choo, I. H., Ni, R., Schöll, M., Wall, A. E., Almkvist, O., & Nordberg, A. K. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121489 · Cited by 57 · see citing works
Amyloid, neurodegeneration, and small vessel disease as predictors of dementia in the oldest-old
López, O. L., Klunk, W. E., Mathis, C. A., Coleman, R. L., Price, J. C., Becker, J. T., Aizenstein, H. J., Snitz, B. E., Cohen, A. D., Ikonomović, M. D., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000977 · Cited by 57 · see citing works
Stable Size Distribution of Amyloid Plaques Over the Course of Alzheimer Disease
Serrano‐Pozo, A., Mielke, M. L., Muzitansky, A., Gómez‐Isla, T., Growdon, J. H., Bacskai, B. J., Betensky, R. A., Frosch, M. P., & Hyman, B. T. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31825e77de · Cited by 56 · see citing works
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment
Brück, A., Virta, J. R., Koivunen, J., Koikkalainen, J. R., Scheinin, N. M., Helenius, H. Y. M., Någren, K., Helin, S., Parkkola, R. K., Viitanen, M. H., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2478-8 · Cited by 53 · see citing works
Self-citationPET Imaging for Early Detection of Alzheimer’s Disease
Bao, W., Jia, H., Finnema, S. J., Cai, Z., Carson, R. E., & Huang, Y. H. (2017) · PET Clinics · doi:10.1016/j.cpet.2017.03.001 · Cited by 54 · see citing works
Dissociation between Brain Amyloid Deposition and Metabolism in Early Mild Cognitive Impairment
Wu, L., Rowley, J., Mohades, S., Leuzy, A., Dauar, M. T., Shin, M., Fonov, V., Jia, J., Gauthier, S. G., Rosa‐Neto, P., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047905 · Cited by 54 · see citing works
Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?
Mather, M. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.05.013 · Cited by 53 · see citing works
How technology is reshaping cognitive assessment: Lessons from the Framingham Heart Study.
Au, R., Piers, R. J., & Devine, S. (2017) · Neuropsychology · doi:10.1037/neu0000411 · Cited by 50 · see citing works
Neuroimaging in the early diagnosis of neurodegenerative disease
Stoessl, A. J. (2012) · Translational Neurodegeneration · doi:10.1186/2047-9158-1-5 · Cited by 48 · see citing works
Leinonen, V., Rinne, J. O., Virtanen, K. A., Eskola, O., Rummukainen, J., Huttunen, J., zu Fraunberg, M. V. U., Nerg, O., Koivisto, A. M., Rinne, J., et al. (2013) · European Journal of Neurology · doi:10.1111/ene.12102 · Cited by 43 · see citing works
Self-citationDisclosure of amyloid imaging results to research participants: Has the time come?
Lingler, J. H., & Klunk, W. E. (2013) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.09.014 · Cited by 43 · see citing works
Ye, B. S., Kim, Y. J., Kim, Y. J., Jung, N., Lee, J. S., Lee, J., Jang, Y. K., Yang, J., Lee, J. M., Vogel, J. W., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23676-w · Cited by 41 · see citing works
Evaluation of neuroprotective effect of glucagon‐like peptide 1 analogs using neuroimaging
Femminella, G. D., & Edison, P. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.12.012 · Cited by 41 · see citing works
Predicting amyloid positivity in patients with mild cognitive impairment using a radiomics approach
Kim, J. P., Kim, J., Jang, H., Kim, J., Kang, S. H., Kim, J. S., Lee, J. M., Na, D. L., Kim, H. J., Seo, S. W., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-86114-4 · Cited by 39 · see citing works
Five-year follow-up of 11C-PIB uptake in Alzheimer’s disease and MCI
Kemppainen, N. M., Scheinin, N. M., Koivunen, J., Johansson, J. J., Toivonen, J., Någren, K., Rokka, J., Karrasch, M., Parkkola, R. K., & Rinne, J. O. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-013-2562-0 · Cited by 38 · see citing works
Self-citationGhosh, S., Libon, D. J., & Lippa, C. F. (2013) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513517040 · Cited by 38 · see citing works
Hanon, O., Vidal, J., Lehmann, S., Bombois, S., Allinquant, B., Rose, C., Tréluyer, J., Abdoul, H., Gelé, P., Delmaire, C., et al. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12613 · Cited by 38 · see citing works
The neurobiology of Alzheimer disease defined by neuroimaging
Masdeu, J. C., Kreisl, W. C., & Berman, K. F. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283557b36 · Cited by 36 · see citing works
Defrancesco, M., Egger, K. E., Marksteiner, J., Esterhammer, R., Hinterhuber, H., Deisenhammer, E., & Schocke, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106062 · Cited by 37 · see citing works
Tentolouris-Piperas, V., Ryan, N. S., Thomas, D. L., & Kinnunen, K. M. (2016) · Brain Research · doi:10.1016/j.brainres.2016.11.011 · Cited by 36 · see citing works
Guo, T., Dukart, J., Brendel, M., Rominger, A., Grimmer, T., Yakushev, I. Y., & Initiative, A. D. N. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.05.013 · Cited by 35 · see citing works
Lim, Y. Y., Ellis, K. A., Harrington, K., Pietrzak, R. H., Gale, J., Ames, D. J., Bush, A. I., Darby, D., Martins, R. N., Masters, C. L., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121771 · Cited by 34 · see citing works
The prognostic value of amyloid imaging
Gelosa, G., & Brooks, D. J. (2012) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2108-x · Cited by 34 · see citing works
Should We Disclose Amyloid Imaging Results to Cognitively Normal Individuals?
Grill, J. D., Johnson, D. K., & Burns, J. M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.12.75 · Cited by 34 · see citing works
Biomarkers in Alzheimer’s Disease
Riverol, M., & López, O. L. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00046 · Cited by 31 · see citing works
Zwan, M. D., Ossenkoppele, R., Tolboom, N., Beunders, A. J. M., Kloet, R. W., Adriaanse, S. M., Boellaard, R., Windhorst, A. D., Raijmakers, P. G. H. M., Adams, H., et al. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.114.139121 · Cited by 31 · see citing works
Ricci, M., Cimini, A., Chiaravalloti, A., Filippi, L., & Schillaci, O. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207481 · Cited by 31 · see citing works
Efficient Near-Infrared In Vivo Imaging of Amyoid-β Deposits in Alzheimer's Disease Mouse Models
Schmidt, A., & Pahnke, J. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112168 · Cited by 30 · see citing works
de Souza, L. C., Lehéricy, S., Dubois, B., Stella, F., & Sarazin, M. (2012) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328357b9ab · Cited by 29 · see citing works
Kaskikallio, A., Karrasch, M., Koikkalainen, J., Lötjönen, J., Rinne, J. O., Tuokkola, T., Parkkola, R., & Grönholm-Nyman, P. (2019) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000506124 · Cited by 28 · see citing works
Self-citationAlzheimer disease: From biomarkers to diagnosis
Dubois, B., Epelbaum, S., Santos, A., Stefano, F. D., Julian, A. G., Michon, A., Sarazin, M., & Hampel, H. J. (2013) · Revue Neurologique · doi:10.1016/j.neurol.2013.07.016 · Cited by 28 · see citing works
Ciarmiello, A., Tartaglione, A., Giovannini, E., Riondato, M., Giovacchini, G., Ferrando, O., Biasi, M. D., Passera, C., Carabelli, E., Mannironi, A., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4149-2 · Cited by 28 · see citing works
Amyloid imaging in prodromal Alzheimer's disease
Ossenkoppele, R., van Berckel, B. N. M., & Prins, N. D. (2011) · Alzheimer s Research & Therapy · doi:10.1186/alzrt88 · Cited by 27 · see citing works
Amyloid-β Load Predicts Medial Temporal Lobe Dysfunction in Alzheimer Dementia
Frings, L., Spehl, T. S., Weber, W., Hüll, M., & Meyer, P. T. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.120378 · Cited by 26 · see citing works
Ferreira, L. K., Tamashiro-Duran, J. H., Squarzoni, P., Duran, F., Alves, T. C. T. F., Buchpiguel, C. A., & Busatto, G. F. (2014) · Brazilian Journal of Psychiatry · doi:10.1590/1516-4446-2013-1275 · Cited by 23 · see citing works
Molecular Imaging of Alzheimer Disease Pathology
Kantarci, K. (2014) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3847 · Cited by 23 · see citing works
P ittsburgh compound B retention and progression of cognitive status – a meta‐analysis
Chen, X., Li, M., Wang, S., Zhu, H., Xiong, Y., & Liu, X. (2014) · European Journal of Neurology · doi:10.1111/ene.12398 · Cited by 22 · see citing works
Rinne, J. O., Frantzén, J., Leinonen, V., Lönnrot, K., Laakso, A., Virtanen, K. A., Solin, O. H., Kotkansalo, A., Koivisto, A. M., Sajanti, J., et al. (2013) · Neurodegenerative Diseases · doi:10.1159/000355256 · Cited by 21 · see citing works
Self-citationWarsi, M. A., Molloy, W., & Noseworthy, M. D. (2012) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-012-0312-0 · Cited by 21 · see citing works
Zhu, Y., Initiative, O. B. O. A. D. N., Gong, L., He, C., Wang, Q., Ren, Q., & Xie, C. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190254 · Cited by 21 · see citing works
Initiative, A. D. N., Liu, Y.-S., Yan, W., Tan, C., Li, J., Xu, W., Cao, X., Tan, L., & Yu, J. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-00105-y · Cited by 21 · see citing works
Cognitive Decline and Amyloid Accumulation in Patients with Mild Cognitive Impairment
Koivunen, J., Karrasch, M., Scheinin, N. M., Aalto, S., Vahlberg, T. J., Någren, K., Helin, S., Viitanen, M. H., & Rinne, J. O. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000341580 · Cited by 21 · see citing works
Self-citationPoinsatte, K., Monson, N. L., Zhang, R., Stowe, A. M., Huebinger, R. M., Cullum, C. M., Monson, N. L., Zhang, R., & Stowe, A. M. (2026) · PubMed · doi:10.22029/eir.2019.1727 · Cited by 20 · see citing works
Added value of amyloid PET in individualized risk predictions for MCI patients
van Maurik, I. S., van der Kall, L. M., de Wilde, A., Bouwman, F. H., Scheltens, P., van Berckel, B. N. M., Berkhof, J. H., van der Flier, W. M., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.04.011 · Cited by 20 · see citing works
Postmortem Pittsburgh Compound B (PiB) Binding Increases with Alzheimer's Disease Progression
Beckett, T. L., Webb, R. L., Niedowicz, D. M., Holler, C. J., Matveev, S., Baig, I., LeVine, H., Keller, J. N., & Murphy, M. P. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120655 · Cited by 18 · see citing works
- Authors
- Koivunen, J., Scheinin, N., Virta, J. R., Aalto, S., Vahlberg, T., Någren, K., Helin, S., Parkkola, R., Viitanen, M., & Rinne, J. O.
- Affiliations
- University of Turku (FI)
- ORCID
- Venue
- Neurology
- Published
- 2011-03-22
- Volume
- 76
- Issue
- 12
- Pages
- 1085-1090
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2143282099
- Cited by
- 188
- References
- 18
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 11 · 2020: 5 · 2019: 12 · 2018: 9 · 2017: 8 · 2016: 12 · 2015: 12 · 2014: 27 · 2013: 30 · 2012: 32
- FWCI
- 21.01
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- amnestic mild cognitive impairment, amyloid-beta deposition, Pittsburgh compound B, amyloid PET, hippocampal atrophy, posterior cingulate cortex, temporal cortex, putamen, longitudinal follow-up
- MeSH terms
- Aged, Alzheimer Disease, Aniline Compounds, Atrophy, Brain, Carbon Radioisotopes, Cognition Disorders, Female, Follow-Up Studies, Humans, Male, Neuropsychological Tests, Thiazoles, Amyloid beta-Peptides, Disease Progression, Positron-Emission Tomography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
